Bristol-Myers Squibb synthesizes novel myeloperoxidase and/or eosinophil peroxidase inhibitors March 24, 2017
Bristol-Myers Squibb divulgues myeloperoxidase and/or eosinophil peroxidase inhibitors March 23, 2017
Eli Lilly and Company discloses new histone-lysine N-methyltransferase EZH2 inhibitors March 23, 2017